ABBV vs BAC: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and Bank of America Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-14.
AbbVie Inc. · Healthcare
$261.07
+1.2% upside to fair value
Grade C
High Quality
VS
Bank of America Corporation · Financial Services
$59.50
-45.0% upside to fair value
Grade C
QuantHub Verdict
ABBV has more upside to fair value
(+1.2%).
BAC trades at a lower forward P/E
(14.6x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
BAC |
| Current Price |
$261.07 |
$59.50 |
| Fair Value Estimate |
$264.30 |
$32.73 |
| Upside to Fair Value |
+1.2%
|
-45.0%
|
| Market Cap |
$461.3B |
$422.2B |
| Forward P/E |
128.0x
|
14.6x
|
| EV / EBITDA |
31.0x
|
13.3x
|
| Price / Sales |
7.3x
|
2.4x
|
| Price / FCF |
22.1x
|
7.5x
|
| Revenue Growth YoY |
+12.4%
|
-35.6%
|
| Gross Margin |
70.7%
|
63.2%
|
| Operating Margin |
27.6%
|
22.9%
|
| Return on Equity |
68.0%
|
10.5%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.52%
|
13.4%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
AbbVie Inc. is a leading healthcare company specializing in drug manufacturing with a strong focus on immunology and aesthetics. The company is transitioning from its historical Humira dominance, which has faced loss of exclusivity, toward high-growth assets like Skyrizi and Rinvoq that are driving robust revenue growth of 12.4% in the most recent quarter. Despite strong revenue growth and a dura…
Bank of America Corporation operates as a diversified bank within the financial services sector, offering a broad range of banking and financial products. The business quality is medium, supported by a 10.5% return on equity and solid margins, but recent revenue declined sharply by 35.6% in the most recent quarter, indicating top-line pressure. Despite earnings growth of 16.1% in the same period,…
Accumulation Zones
| Metric |
ABBV |
BAC |
| Zone Low |
$198.23 |
$24.55 |
| Zone High |
$224.66 |
$27.82 |
| In Buy Zone? |
No
|
No
|